miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gliomas are aggressive brain tumors with poor prognoses, driven by complex molecular mechanisms including altered gene expression and epigenetic modifications.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play critical roles in cell growth, proliferation, and migration, making them relevant to cancer development.
• While miR-139 has shown anti-tumor functions in various cancers, its specific mechanisms in glioma remain incompletely understood.

Purpose of the Study:

• To investigate the role and molecular mechanisms of miR-139 in glioma progression.
• To validate the expression levels of miR-139 in glioma tissues and cell lines.
• To identify direct targets of miR-139 and elucidate their contribution to glioma proliferation and invasion.

Main Methods:

• Quantitative real-time PCR to assess miR-139 expression levels in glioma tissues and cell lines.
• In vitro assays (proliferation, invasion) and in vivo xenograft models to evaluate the functional impact of miR-139.
• Bioinformatic analysis and luciferase reporter assays to identify and validate direct miR-139 targets: insulin-like growth factor 1 receptor (IGF1R), associate of Myc 1 (AMY1), and peroxisome proliferator-activated receptor γ coactivator 1β (PGC1β).
• Western blotting and signaling pathway analysis (Akt, c-Myc) to investigate the downstream effects of target gene modulation.

Main Results:

• miR-139 expression was significantly downregulated in glioma tissues and cell lines compared to normal controls.
• Overexpression of miR-139 suppressed glioma cell proliferation and invasion in vitro and inhibited tumor growth in vivo.
• IGF1R, AMY1, and PGC1β were identified as direct targets of miR-139, with their expression inversely correlated with miR-139 levels in gliomas.
• IGF1R promoted invasion via the Akt pathway and proliferation via PGC1β, while AMY1 facilitated progression through the c-Myc pathway.
• Restoring the expression of these target genes partially rescued the anti-tumor effects of miR-139.

Conclusions:

• miR-139 functions as a tumor suppressor in gliomas by targeting IGF1R, AMY1, and PGC1β, thereby inhibiting proliferation and invasion.
• The findings elucidate a novel regulatory network involving miR-139 and its targets, offering new insights into glioma pathogenesis.
• miR-139 holds promise as a potential prognostic biomarker and a novel therapeutic target for glioma treatment.